Suchergebnisse - "PD1"

PubPharm (15.822)

1

PD-1 regulation in immune homeostasis and immunotherapy

enthalten in: Cancer letters | 2024

von Gao, M. | Shi, J. | Xiao, X. | +4

2

Clinical characteristics associated with efficacy and prognosis among patients treated with PD-1/PD-L1 inhibitors for early-stage triple-negative breast cancers : A meta-analysis

enthalten in: Critical reviews in oncology/hematology | 2024

von Wei, Y. | Wu, Y. | Luo, Y. | +1

3

Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer

enthalten in: Cancer letters | 2024

von Cao, C. | Xu, Q. | Zhu, Z. | +20

4

DNA-delivered monoclonal antibodies targeting the p53 R175H mutant epitope inhibit tumor development in mice

enthalten in: Genes & diseases | 2024

von Chai, D. | Wang, X. | Neeli, P. | +4

5

Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma

enthalten in: Anticancer research | 2024

von Koh, Y. | Han, J. | Haam, S. | +1

6

Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica

enthalten in: Rheumatic diseases clinics of North America | 2024

von Liew, D. | Mackie, S. | Tison, A. | +4

7

Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma : a systematic review and network meta-analysis

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Liang, Y. | Gan, L. | Zeng, D. | +4

8

Discovery of bioactive natural products of microbial origin as inhibitors of the PD-1/PD-L1 protein-protein interaction

enthalten in: International journal of biological macromolecules | 2024

von Domingo-Contreras, E. | Tormo, J. | Gonzalez-Menendez, V. | +9

9

A combined model of serum neutrophil extracellular traps, CD8+ T cells, and tumor proportion score provides better prediction of PD-1 inhibitor efficacy in patients with NSCLC

enthalten in: The FEBS journal | 2024

von Guo, J. | Shu, T. | Zhang, H. | +11

10

Unveiling the role of FTO polymorphisms in predicting response to immune checkpoint inhibitors : A retrospective study

enthalten in: International immunopharmacology | 2024

von Liu, W. | Xiao, C. | Luo, J. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1583]